Eleven Biotherapeutics

SEC Filings
 

 
SEC Filings
Date Filed Filing Description View
February 5, 2014 3 afeyan noubar HTML PDF XLS Add to Briefcase
March 24, 2014 4 afeyan, noubar HTML PDF XLS Add to Briefcase
December 6, 2016 8-K/A amended current report HTML PDF XLS Add to Briefcase
September 19, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
September 23, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 18, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 30, 2016 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
April 7, 2017 SC 13D/A amended general statement of beneficial ownership HTML PDF XLS Add to Briefcase
November 6, 2015 10-Q/A amended quarterly report HTML PDF XLS Add to Briefcase
October 13, 2010 D/A amended small company offering and sale of securities without registration HTML PDF
Add to Briefcase
1
... NextLast
Add to Briefcase = add PDF file to Briefcase
NASDAQ: EBIO
Price:
1.51
Change:
- 0.03
Day High:
1.55
Day Low:
1.50
Volume:
90,696
3:59 PM ET on July 21, 2017
Delayed at least 20 minutes.